Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-24-043461
Filing Date
2024-10-23
Accepted
2024-10-23 17:03:24
Documents
3
Period of Report
2024-10-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1729717397.html 3  
1 FORM 3 wk-form3_1729717397.xml 3 1673
2 EX-24 formsection16powerofatto.htm EX-24 3684
3 formsection16powerofatto001.jpg GRAPHIC 239186
  Complete submission text file 0001628280-24-043461.txt   336428
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Issuer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)

Mailing Address 2443 FILLMORE ST #380-17649 SAN FRANCISCO CA 94115
Business Address
Pamir Ozan (Reporting) CIK: 0001834681 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37752 | Film No.: 241389744